Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
Clinical trial NCT07057427 · RECRUITING
Trial details
- NCT number
- NCT07057427
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-24
- Primary completion
- 2028-06-30
- Enrollment
- 812
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.